1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Macular Degeneration 1.2.3 Diabetic Macular Edema 1.2.4 Diabetic Retinopathy 1.2.5 Retinal Vein Occlusion 1.3 Market by Application 1.3.1 Global Retinal Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Retinal Disease Therapeutics Market Perspective (2016-2027) 2.2 Retinal Disease Therapeutics Growth Trends by Regions 2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Retinal Disease Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Retinal Disease Therapeutics Industry Dynamic 2.3.1 Retinal Disease Therapeutics Market Trends 2.3.2 Retinal Disease Therapeutics Market Drivers 2.3.3 Retinal Disease Therapeutics Market Challenges 2.3.4 Retinal Disease Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Retinal Disease Therapeutics Players by Revenue 3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue 3.4 Global Retinal Disease Therapeutics Market Concentration Ratio 3.4.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2020 3.5 Retinal Disease Therapeutics Key Players Head office and Area Served 3.6 Key Players Retinal Disease Therapeutics Product Solution and Service 3.7 Date of Enter into Retinal Disease Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Retinal Disease Therapeutics Breakdown Data by Type 4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2022-2027) 5 Retinal Disease Therapeutics Breakdown Data by Application 5.1 Global Retinal Disease Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Retinal Disease Therapeutics Market Size (2016-2027) 6.2 North America Retinal Disease Therapeutics Market Size by Type 6.2.1 North America Retinal Disease Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Retinal Disease Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Retinal Disease Therapeutics Market Size by Type (2016-2027) 6.3 North America Retinal Disease Therapeutics Market Size by Application 6.3.1 North America Retinal Disease Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Retinal Disease Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Retinal Disease Therapeutics Market Size by Application (2016-2027) 6.4 North America Retinal Disease Therapeutics Market Size by Country 6.4.1 North America Retinal Disease Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Retinal Disease Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Retinal Disease Therapeutics Market Size (2016-2027) 7.2 Europe Retinal Disease Therapeutics Market Size by Type 7.2.1 Europe Retinal Disease Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Retinal Disease Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Retinal Disease Therapeutics Market Size by Type (2016-2027) 7.3 Europe Retinal Disease Therapeutics Market Size by Application 7.3.1 Europe Retinal Disease Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Retinal Disease Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Retinal Disease Therapeutics Market Size by Application (2016-2027) 7.4 Europe Retinal Disease Therapeutics Market Size by Country 7.4.1 Europe Retinal Disease Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Retinal Disease Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type 8.2.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application 8.3.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Region 8.4.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Retinal Disease Therapeutics Market Size (2016-2027) 9.2 Latin America Retinal Disease Therapeutics Market Size by Type 9.2.1 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Retinal Disease Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Retinal Disease Therapeutics Market Size by Application 9.3.1 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Retinal Disease Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Retinal Disease Therapeutics Market Size by Country 9.4.1 Latin America Retinal Disease Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Retinal Disease Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Retinal Disease Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type 10.2.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application 10.3.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Retinal Disease Therapeutics Market Size by Country 10.4.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Retinal Disease Therapeutics Introduction 11.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.1.5 Merck Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Retinal Disease Therapeutics Introduction 11.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Allergan 11.3.1 Allergan Company Details 11.3.2 Allergan Business Overview 11.3.3 Allergan Retinal Disease Therapeutics Introduction 11.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.3.5 Allergan Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Retinal Disease Therapeutics Introduction 11.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Regeneron 11.5.1 Regeneron Company Details 11.5.2 Regeneron Business Overview 11.5.3 Regeneron Retinal Disease Therapeutics Introduction 11.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.5.5 Regeneron Recent Development 11.6 Santen 11.6.1 Santen Company Details 11.6.2 Santen Business Overview 11.6.3 Santen Retinal Disease Therapeutics Introduction 11.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2016-2021) 11.6.5 Santen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Macular Degeneration Table 3. Key Players of Diabetic Macular Edema Table 4. Key Players of Diabetic Retinopathy Table 5. Key Players of Retinal Vein Occlusion Table 6. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Retinal Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Retinal Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Retinal Disease Therapeutics Market Share by Regions (2016-2021) Table 10. Global Retinal Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Retinal Disease Therapeutics Market Share by Regions (2022-2027) Table 12. Retinal Disease Therapeutics Market Trends Table 13. Retinal Disease Therapeutics Market Drivers Table 14. Retinal Disease Therapeutics Market Challenges Table 15. Retinal Disease Therapeutics Market Restraints Table 16. Global Retinal Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Retinal Disease Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2020) Table 19. Ranking of Global Top Retinal Disease Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Retinal Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Retinal Disease Therapeutics Product Solution and Service Table 23. Date of Enter into Retinal Disease Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Retinal Disease Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Retinal Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Retinal Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Retinal Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Retinal Disease Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Retinal Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Retinal Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. Merck Company Details Table 64. Merck Business Overview Table 65. Merck Retinal Disease Therapeutics Product Table 66. Merck Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 67. Merck Recent Development Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Retinal Disease Therapeutics Product Table 71. Novartis Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 72. Novartis Recent Development Table 73. Allergan Company Details Table 74. Allergan Business Overview Table 75. Allergan Retinal Disease Therapeutics Product Table 76. Allergan Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 77. Allergan Recent Development Table 78. Roche Company Details Table 79. Roche Business Overview Table 80. Roche Retinal Disease Therapeutics Product Table 81. Roche Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 82. Roche Recent Development Table 83. Regeneron Company Details Table 84. Regeneron Business Overview Table 85. Regeneron Retinal Disease Therapeutics Product Table 86. Regeneron Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 87. Regeneron Recent Development Table 88. Santen Company Details Table 89. Santen Business Overview Table 90. Santen Retinal Disease Therapeutics Product Table 91. Santen Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million) Table 92. Santen Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Macular Degeneration Features Figure 3. Diabetic Macular Edema Features Figure 4. Diabetic Retinopathy Features Figure 5. Retinal Vein Occlusion Features Figure 6. Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacy Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Others Case Studies Figure 10. Retinal Disease Therapeutics Report Years Considered Figure 11. Global Retinal Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Retinal Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Retinal Disease Therapeutics Market Share by Regions: 2020 VS 2027 Figure 14. Global Retinal Disease Therapeutics Market Share by Regions (2022-2027) Figure 15. Global Retinal Disease Therapeutics Market Share by Players in 2020 Figure 16. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2020 Figure 18. Global Retinal Disease Therapeutics Revenue Market Share by Type (2016-2021) Figure 19. Global Retinal Disease Therapeutics Revenue Market Share by Type (2022-2027) Figure 20. North America Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Retinal Disease Therapeutics Market Share by Type (2016-2027) Figure 22. North America Retinal Disease Therapeutics Market Share by Application (2016-2027) Figure 23. North America Retinal Disease Therapeutics Market Share by Country (2016-2027) Figure 24. United States Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Retinal Disease Therapeutics Market Share by Type (2016-2027) Figure 28. Europe Retinal Disease Therapeutics Market Share by Application (2016-2027) Figure 29. Europe Retinal Disease Therapeutics Market Share by Country (2016-2027) Figure 30. Germany Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Retinal Disease Therapeutics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Retinal Disease Therapeutics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Retinal Disease Therapeutics Market Share by Region (2016-2027) Figure 40. China Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Retinal Disease Therapeutics Market Share by Type (2016-2027) Figure 48. Latin America Retinal Disease Therapeutics Market Share by Application (2016-2027) Figure 49. Latin America Retinal Disease Therapeutics Market Share by Country (2016-2027) Figure 50. Mexico Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Retinal Disease Therapeutics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Retinal Disease Therapeutics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Retinal Disease Therapeutics Market Share by Country (2016-2027) Figure 56. Turkey Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 61. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 62. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 63. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 64. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Merck Novartis Allergan Roche Regeneron Santen